🇺🇸 Ranibizumab (Lucentis) in United States

6 US adverse-event reports

Safety signals — FAERS

Adverse reaction reports describe suspected side effects. A report does not mean the drug caused the event — co-medications, underlying disease and coincidence all contribute.

Most-reported reactions

  1. Cardiac Failure Congestive — 1 report (16.67%)
  2. Cardiac Murmur — 1 report (16.67%)
  3. Condition Aggravated — 1 report (16.67%)
  4. Dyspnoea — 1 report (16.67%)
  5. Fatigue — 1 report (16.67%)
  6. Feeling Abnormal — 1 report (16.67%)

Source database →

Other Ophthalmology approved in United States

Frequently asked questions

Is Ranibizumab (Lucentis) approved in United States?

Ranibizumab (Lucentis) does not currently have US marketing authorisation in our dataset.

Who is the marketing authorisation holder for Ranibizumab (Lucentis) in United States?

Greater Houston Retina Research is the originator. The local marketing authorisation holder may differ — check the official source linked above.